Discovery of Polyphenolic Natural Products as SARS-CoV-2 M[sup.pro] Inhibitors for COVID-19
Discovery of Polyphenolic Natural Products as SARS-CoV-2 M[sup.pro] Inhibitors for COVID-19
About this item
Full title
Author / Creator
Publisher
MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
MDPI AG
Subjects
More information
Scope and Contents
Contents
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has forced the development of direct-acting antiviral drugs due to the coronavirus disease 2019 (COVID-19) pandemic. The main protease of SARS-CoV-2 is a crucial enzyme that breaks down polyproteins synthesized from the viral RNA, making it a validated target for the development of SA...
Alternative Titles
Full title
Discovery of Polyphenolic Natural Products as SARS-CoV-2 M[sup.pro] Inhibitors for COVID-19
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A743326791
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A743326791
Other Identifiers
ISSN
1424-8247
E-ISSN
1424-8247
DOI
10.3390/ph16020190
